Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis (SLA_Vit_D)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02893605|
Recruitment Status : Completed
First Posted : September 8, 2016
Last Update Posted : July 19, 2017
|Condition or disease|
|Amyotrophic Lateral Sclerosis|
|Study Type :||Observational|
|Actual Enrollment :||800 participants|
|Official Title:||Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||May 2017|
|Actual Study Completion Date :||May 2017|
Patients have a sporadic form of Amyotrophic Lateral Sclerosis.
Controls correspond to spouses/partners of patients.
- The polymorphisms occurring on a pre-defined set of genes [ Time Frame: Day 0 (transversal study) ]The genes studied are: CYP2R1, CYP27A1, CYP3A4, CYP2J2, CYP27B1, CYP24A1, VDBP, VDR.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02893605
|CHU de Montpellier - Hôpital Gui de Chauliac|
|Montpellier Cedex 5, France, 34295|
|Principal Investigator:||Kevin Mouzat, MD, PhD||Centre Hospitalier Universitaire de Nîmes|